OVERVIEW

Cancer

Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
 
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
CANCER RESEARCH PROGRAMS
Click a program below to learn more
 
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
GALLERY
Interview with Prof John Hooper about pancreatic cancer research
Event
TRI Cancer Seminar Speakers: Fiona Simpson (UQDI) on 'Breast cancer, Herceptin and Girdin' and Gregor Tetz (QUT) on 'Co-targeting H2 relaxin and androgen signally in prostate cancer'.Read more
Article
New gene research helps pinpoint prostate cancer risk Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-...Read more
Event
TRI Cancer Seminar Inga Mertens presents ‘Investigating downstream targets of EphB4 - Role of integrin β8 in prostate cancer’ Kristeen Tullet presentation TBC.Read more
Article
TALENTED TRI-BASED RESEARCHERS RECOGNISED AT WOMEN IN TECHNOLOGY AWARDS The outstanding work of TRI researchers has been recognised with two winners at the 17th Annual Women in Technology (WiT)...Read more
Article
prostate cancer drugs made more effective More than 20,000 Australian men are diagnosed with prostate cancer each year – and the disease kills 3,300 annually. “The death rate of men from...Read more
Event
Fifth biennial queensland neuroma conference Acoustic Neuroma (Vestibular Schwannoma) is a Schwann cell derived tumour arising from the Eighth cranial nerve (hearing and balance nerve), found in the...Read more
Article
‘Near patient’ research program targets blood cancer Research into blood cancer will be boosted with a new high-level appointment at the University of Queensland Diamantina Institute...Read more
Article
Research on the genetic biomarkers of prostate cancer aimed at improving early diagnosis of the cancer to enable targeted treatment, has won QUT geneticist Dr Jyotsna Batra a top Indian award. Dr...Read more
Event
QIMR Special Seminar - 12 August Associate Professor Pam Pollock, QUT, Brisbane FGFR2 mutations in endometrial cancer - are we ready for the clinic? Hosted by Dr Steven Lane, Translational Leukaemia...Read more
Article
Research into skin, blood and breast cancers has been ramped up in Queensland with the opening of the southern hemisphere’s largest and most sophisticated genome sequencing centre. The $2...Read more

Pages